Abionic teams up with Genentech to develop rapid Asthma test

Abionic has signed an agreement with Genentech to develop and provide rapid Point-of-Care tests for Asthma in the US. The technical basis is Abionic’s POC abioSCOPE platform, a compact, ultra-fast medical device powered by a patented nanofluidic technology.